Overview
The objectives of this study are the assessment of the clinical, radiographical and patient-reported outcomes of SMR Stemless Reverse Shoulder Arthroplasty (LimaCorporate S.p.A.) used as standard of care over a period of at least 2 years of follow-up and the evaluation of the incidence of any complication.
Description
The focus of this study is the evaluation on clinical, patient-reported and radiographical outcomes of SMR Stemless Reverse Shoulder Arthroplasty. There is a retrospective and prospective study population.
The follow up time-points are (as of standard of care and not different for this study):
- Baseline
- 6 weeks postop
- 6 months postop
- 12 months postop
- 24 months postop
Eligibility
Inclusion Criteria:
- rotator-cuff arthropathy, osteoarthritis
- approving written informed consent
Exclusion Criteria:
- Female patients who are pregnant, nursing, or planning a pregnancy.
- All adult patients with any of the SMR Stemless contraindication for use for the reverse configuration as reported in the current local Instruction for use.
- not consenting in participating in this study